Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of the Listing Regulations, enclosed herewith are the details of the meeting scheduled with an Analyst/Institutional Investor. Please note that the enclosed schedule is subject to change on account of exigencies on the part of the Analyst/Institutional Investor or the Company. The enclosed schedule shall also be displayed on the website of the Company - www.pfizerindia.com in compliance with the Regulation 46 of the Listing Regulations.
16-03-2018
Bigul

Reckitt Benckiser stands by Mead Johnson deal, despite Pfizer option

 The CEO told Reuters that the Mead Johnson acquisition had already benefited Reckitt, although it has only just reversed several quarters of decline in that business
10-03-2018
Bigul

Announcement under Regulation 30 (LODR)-Change in Directorate

 We refer to our letter dated February 19, 2018, wherein it was intimated that Mr. Ravi Prakash Bhagavathula had tendered his resignation as Executive Director - Finance and Chief Financial Officer with effect from such date as may be agreed between Mr. Ravi Prakash Bhagavathula and the Board of Directors. In furtherance to the same, we would like to inform that Mr. Ravi Prakash Bhagavathula has resigned as Executive...
01-03-2018
Bigul

Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Please find enclosed press release in connection with the inclusion of certain brands in the global strategic alternatives review for Consumer Healthcare business. Please take the above on record.
01-03-2018
Bigul

Announcement under Regulation 30 (LODR)-Updates

 Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
01-03-2018
Bigul

Announcement under Regulation 30 (LODR)-Change in Directorate

 This is to inform you that Mr. Ravi Prakash Bhagavathula has tendered his resignation as the Executive Director - Finance & Chief Financial Officer of Pfizer Limited to pursue opportunities outside Pfizer effective such date as may be agreed between Mr. Bhagavathula and the Board of Directors of the Company.
19-02-2018

Glaxo, Reckitt are said only bidders for Pfizer's consumer unit

 GlaxoSmithKline and Reckitt Benckiser are the only companies to have submitted non-binding bids for Pfizer's consumer business after rival candidates walked away
03-02-2018

ICMR partners with Pfizer to combat antimicrobial resistance

 The joint initiative will implement a series of comprehensive interventions, ranging from AMR stewardship programmes for nursing homes to scaling up of the ongoing AMR surveillance network
01-02-2018
Bigul

Drug firm Pfizer Q3 net profit surges 40% to Rs 872 mn on lower expenses

 The company had posted a net profit of Rs 623 million during the same period of the previous fiscal
25-01-2018
Bigul

Press Release / Media Release

 Please find enclosed press release for the financial results for the quarter and nine months ended December 31, 2017. Please take the above on record.
24-01-2018
Next Page
Close

Let's Open Free Demat Account